|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | NMDA receptor involvement in spatial delayed alternation in developing rats显示文摘 | Deborah J Watson Mariel R | 2009 | Behav Neurosci2009，123，1： | 1 |
| 2 | Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development显示文摘 | Diana M. Colleluori Deborah Tien Feirong Kang Tara Pagliei Ryan Kuss Timothy McCormick Karen Watson Karyn McFadden Irwin Chaiken Robert W. Buckheit Joseph W. Romano | 2004 | Protein Expression and Purification2004，，2： | 1 |
| 3 | The REMATCH trial: rationale, design, and end points显示文摘 | Eric A Rose Alan J Moskowitz Milton Packer Josephine A Sollano Deborah L Williams Anita R Tierney Daniel F Heitjan Paul Meier Deborah Davis Ascheim Ronald G Levitan Alan D Weinberg Lynne Warner Stevenson Peter A Shapiro Ronald M Lazar John T Watson Daniel | 1999 | The Annals of Thoracic Surgery1999，，3： | 1 |
| 4 | Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage显示文摘 | Watson H Deborah S K | 1993 | Human Reproduction1993，8，6： | 1 |
| 5 | 鼻中隔穿孔的外科治疗显示文摘鼻中隔穿孔在临床中相对比较常见,在一般人群中的发病率约为0.9%。鼻中隔穿孔的治疗对于鼻科及鼻整形外科医师来说是一挑战。 | Deborah Watson Gregory Barkdull 张天振 张庆泉 | 2011 | 中国医学文摘(耳鼻咽喉科学)2011，26，3： | 1 |
| 6 | GDNF, NGF and BDNF as therapeutic options for neurodegeneration显示文摘 | Shelley J. Allen Judy J. Watson Deborah K. Shoemark Neil U. Barua Nikunj K. Patel | 2013 | Pharmacology and Therapeutics2013，，2： | 1 |
| 7 | A phylogeny of the flowering plant family Apiaceae based on chloroplast DNA rpl16 and rpoc1 intron sequences:towards a suprageneric classification of subfamily Apioideae显示文摘 | DOWNIE STEPHEN R KATZ-DOWNIE DEBORAH S WATSON MARK F | 2000 | American Journal of Botany2000，87，2： | 1 |
| 8 | Genomic information of children with malignant brain tumors for the prediction of length of hospitalization显示文摘Dear Editor:Central nervous system tumors in the brain or spine are the most common solid tumors in children,which accounts for about 25%of cancers in children younger than 15 years of age,and are the most common cause of cancer deaths in children[1].The 5-year survival rate for central nervous system neoplasms has increased dramatically to 74%for patients under 18 years old(97%for benign/borderline malignant tumors)in 2022,compared to 20%in the 1970s[1].Without cure treatments and specific medications for many brain cancers,the dramatic increase of survival rate is largely due to improved hospital care and availability of clinical resources.The length of hospitalization of pediatric patients with brain cancer is an important indicator of prognosis as it reflects the required medical effort needed to care for these patients.The length of hospitalization is also critical for the healthcare system as hospital admission is a part of the care trajectory of the respective patients,related to the cost of medical care[2,3]. | Yichuan Liu Hui-Qi Qu Xiao Chang Frank D Mentch Haijun Qiu Kenny Nguyen Xiang Wang Amir Hossein Saeidian Deborah Watson Joseph Glessner Hakon Hakonarson | 2023 | Cancer Communications2023，43，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员